infliximab-abda

infliximab-abda (RENFLEXIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

RENFLEXIS is a marketed brand name for infliximab-abda. Check FDA Drugs@FDA for the current US label holder and prescribing information.

infliximab-abda has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.